Respiratory syncytial virus is common but it can be dangerous for some infants and young kids. Here's everything parents need ...

Another preventive measure is monoclonal antibodies — artificially created proteins that can be given to infants to assist ...

Understanding the differences between colds, flu, and RSV can help in identifying the illness you're dealing with, the ...

The eight new ACIP members met for the first time June 25 after Kennedy fired all 17 original members of the committee June 9 ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...

For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...

FEV1/FVC was significantly lower in young adults who had severe bronchiolitis during infancy vs those who did not. Severe bronchiolitis during infancy may contribute to irreversible airway obstruction ...

A major UK-led clinical trial has found that a treatment commonly used to help premature babies breathe offers no benefit for ...

EMA accepts for regulatory review GSK’s RSV vaccine, Arexvy to expand use in adults 18 years and older: London, UK Saturday, June 14, 2025, 10:00 Hrs [IST] GSK plc announced tha ...